Schedule 13D ownership disclosure

PDL BIOPHARMA INC

Security class unavailable · CUSIP: 69329Y104

Event date: 2020-12-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
20.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001123292-21-000068
Form type
SC 13D
Filer
PDL BIOPHARMA, INC.
CIK
CIK 882104
Filed
Jan 11, 2021
Reporting period
Dec 30, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub